AD Hess

672 total citations
16 papers, 554 citations indexed

About

AD Hess is a scholar working on Hematology, Immunology and Infectious Diseases. According to data from OpenAlex, AD Hess has authored 16 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in AD Hess's work include Hematopoietic Stem Cell Transplantation (14 papers), Immunotherapy and Immune Responses (6 papers) and T-cell and B-cell Immunology (5 papers). AD Hess is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Immunotherapy and Immune Responses (6 papers) and T-cell and B-cell Immunology (5 papers). AD Hess collaborates with scholars based in United States. AD Hess's co-authors include Vogelsang Gb, GW Santos, WE Beschorner, PJ Tutschka, RJ Jones, V Altomonte, AM Yeager, ER Farmer, RB Geller and GB Vogelsang and has published in prestigious journals such as Blood, Bone Marrow Transplantation and PubMed.

In The Last Decade

AD Hess

16 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AD Hess United States 11 376 261 76 54 53 16 554
Elfenbein Gj United States 16 369 1.0× 182 0.7× 122 1.6× 66 1.2× 41 0.8× 36 550
R Brown United States 12 371 1.0× 159 0.6× 126 1.7× 76 1.4× 60 1.1× 20 516
Goldman Jm United Kingdom 11 274 0.7× 131 0.5× 91 1.2× 61 1.1× 46 0.9× 17 485
L Markling Sweden 13 310 0.8× 233 0.9× 53 0.7× 63 1.2× 72 1.4× 28 616
van Rood Jj Netherlands 14 220 0.6× 302 1.2× 51 0.7× 55 1.0× 44 0.8× 70 625
Kun Soo Lee South Korea 12 287 0.8× 126 0.5× 98 1.3× 43 0.8× 70 1.3× 43 449
N Hirabayashi Japan 13 400 1.1× 221 0.8× 208 2.7× 133 2.5× 81 1.5× 45 667
Yasuhiko Miyazaki Japan 13 257 0.7× 142 0.5× 123 1.6× 35 0.6× 117 2.2× 35 516
G Prentice Australia 7 210 0.6× 85 0.3× 103 1.4× 63 1.2× 71 1.3× 13 387
Roseanna Hargreaves United Kingdom 14 232 0.6× 550 2.1× 160 2.1× 38 0.7× 95 1.8× 22 856

Countries citing papers authored by AD Hess

Since Specialization
Citations

This map shows the geographic impact of AD Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AD Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AD Hess more than expected).

Fields of papers citing papers by AD Hess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AD Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AD Hess. The network helps show where AD Hess may publish in the future.

Co-authorship network of co-authors of AD Hess

This figure shows the co-authorship network connecting the top 25 collaborators of AD Hess. A scholar is included among the top collaborators of AD Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AD Hess. AD Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vogelsang, GB, Steven Piantadosi, V Altomonte, et al.. (1999). Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial. Bone Marrow Transplantation. 24(6). 637–640. 16 indexed citations
2.
Vogelsang, GB & AD Hess. (1994). Graft-versus-host disease: new directions for a persistent problem. Blood. 84(7). 2061–2067. 7 indexed citations
3.
Gb, Vogelsang & AD Hess. (1994). Graft-versus-host disease: new directions for a persistent problem. Blood. 84(7). 2061–2067. 90 indexed citations
4.
Hess, AD. (1994). Syngeneic/Autologous Graft-vs-Host Disease: Mobilization of Autoimmune Mechanisms as Antitumor Immunotherapy.. PubMed. 1(3). 201–207. 4 indexed citations
9.
Gb, Vogelsang, et al.. (1989). Therapy of chronic graft-v-host disease in a rat model. Blood. 74(1). 507–511. 22 indexed citations
10.
Gb, Vogelsang, et al.. (1989). Therapy of chronic graft-v-host disease in a rat model. Blood. 74(1). 507–511. 27 indexed citations
11.
Hess, AD, et al.. (1988). Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.. PubMed. 20(2 Suppl 2). 29–40. 81 indexed citations
12.
Hess, AD, et al.. (1988). Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.. PubMed. 20(3 Suppl 3). 487–92. 3 indexed citations
13.
Hess, AD, et al.. (1987). Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.. PubMed. 19(1 Pt 3). 2683–6. 13 indexed citations
14.
Tutschka, PJ, WE Beschorner, AD Hess, & GW Santos. (1983). Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. Blood. 61(2). 318–325. 77 indexed citations
15.
Tutschka, PJ, WE Beschorner, AD Hess, & GW Santos. (1983). Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. Blood. 61(2). 318–325. 3 indexed citations
16.
Cunningham, Brian T., et al.. (1980). Plasmapheresis as immunotherapeutic modality in the treatment of the canine venereal tumor.. PubMed. 8(9). 1123–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026